Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-25

Clinical Trial Update: Fractionated 1927-nm Non Ablative Thulium Laser in Treating Post Inflammatory Hyperpigmentation [NA]

View source ↗

Summary

Henry Ford Health System is recruiting participants to evaluate a fractionated 1927-nm non-ablative thulium laser for treating post-inflammatory hyperpigmentati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fractionated 1927-nm Non Ablative Thulium Laser

Snippet

Sponsor: Henry Ford Health System | Conditions: Healthy | NA | Status: RECRUITING